Decipher Labs Ltd.

17.79 -0.14 ▼-0.8%

29 February 2024, 04:01:00 PM
Volume: 11,407

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.decipherlabs.in
Market Cap 17.75 Cr.
Enterprise Value(EV) 18.11 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -7.08 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.39 Trailing Twelve Months Ending 2023-12
Book Value / Share 20.41 Trailing Twelve Months Ending 2023-12
Price to Book Value 0.86 Calculated using Price: 17.57
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.01 Cr. 10,100,000 Shares
FaceValue 10
About Decipher Labs Ltd.
Combat is a professionally managed, well established public limited company, engaged in the manufacture & marketing of Pharmaceutical Formulations since its incorporation in 1986. The company has been marketing its branded formulations and entering into agreements with various companies for custom manufacturing and has grown to be known as a quality provider.

Decipher Labs Ltd. Delivery

Delivered Qty
Traded Qty

Decipher Labs Ltd. Performance

1 Day
-0.78%
1 Week
-2.36%
1 Month
-12.79%
3 Month
+6.46%
6 Month
+12.45%
1 Year
-9.23%
2 Year
-75.88%
5 Year
-18.21%
10 Year
+215.43%

Decipher Labs Ltd. Fundamental Ratios

6 years 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.6 17.45 14.59 10.69 60.15 -11.32
Return on Capital Employed (%) 8.1 17.95 18.11 13.09 40.71 -12.54
Return on Assets (%) 6.16 8.71 5.28 3.79 28.24 -7.76

Decipher Labs Ltd. Balance Sheet

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2 3 13 14 24 23 21
Non Curr. Liab. 1 8 7 -1 -1
Curr. Liab. 1 4 21 17 11 5 3
Minority Int.
Equity & Liab. 3 6 35 39 42 27 23
Non Curr. Assets 0 13 16 4 7 7
Curr. Assets 3 6 23 23 38 20 17
Misc. Exp. not W/O
Total Assets 3 6 35 39 42 27 23

Decipher Labs Ltd. Profit and Loss

Particulars 7 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 1 8 24 56 65 46 35
Other Income 0 0 1 8 7 0
Total Income 1 8 24 56 73 53 35
Total Expenditure -1 -8 -21 -52 -59 -54 -41
PBIDT 0 0 3 4 14 -1 -6
Interest 0 -1 -1 0 0 0
Depreciation -1 -1 -1 0 0
Taxation 0 0 -1 -1 1 -1
Exceptional Items -2
PAT 0 0 1 1 11 -3 -7
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 0 0 1 1 11 -3 -7
Adjusted EPS 0 1 1 1 11 -3 -7

Decipher Labs Ltd. Cash Flow

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -15 2 8 -2
Cash Fr. Inv. 0 0 0 0 -4
Cash Fr. Finan. 0 0 16 4 1 -2
Net Change 0 0 1 6 9 -8
Cash & Cash Eqvt 0 0 1 7 15 7

Decipher Labs Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 39.01 34.19 34.19 16.43 16.43 16.43 16.43 16.43 16.43
Public 60.99 65.81 65.81 83.57 83.57 83.57 83.57 83.57 83.57
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 7.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Decipher Labs Ltd. Announcements

Tue, 20 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI( LODR) Regulations 2015
Wed, 14 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting For The Quarter 31.12.2023 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
With reference to the subject cited this is to inform the Exchange that the Board of Directors of Decipher Labs Limited at its meeting held on Wednesday the 14th day of February 2024 at 5.00 P.M. at registered office of the Company for the quarter ended 31.12.2023 considered and approved the following: 1. Un- Audited Financial Results (standalone and consolidated) for the quarter and nine months ended 31.12.2023. (Attached)2. Limited Review Report (standalone and consolidated) for the Quarter and nine months ended 31.12.2023. (Attached)
Wed, 14 Feb 2024
Unaudited Financial Results ( Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2023
Unaudited financial results ( standalone and consolidated ) for the quarter nine months ended 31.12.2023

Decipher Labs Ltd. Technical Scans

Wed, 28 Feb 2024
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 2 Years High Decrease in 2 Years

Decipher Labs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 377,475.37 1,577.95 +0.3%
Cipla Ltd. 119,187.32 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. 107,206.64 6,424.25 -0.1%
Zydus Lifesciences Ltd. 94,418.40 941.90 +1.0%
Divi's Laboratories Ltd. 93,236.55 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. 91,390.97 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. 88,302.11 2,666.80 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.38 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 32.14 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.51 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.75 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 67.42 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.78 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,666.80 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.05 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-12 4.60 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.99 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.86 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.15 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.53 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,666.80 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,666.80 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,666.80 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,577.95 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,480.35 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,424.25 -0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 941.90 +1.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,489.10 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,105.90 -3.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,666.80 +2.2%

Decipher Labs Ltd. FAQ's

What is Decipher Labs share price?

Can I buy Decipher Labs shares now?

What is the Market Cap of Decipher Labs?

What are the key metrics to analyse Decipher Labs?

What is the 52 Week High and Low of Decipher Labs?

What is the trend of Decipher Labs share price?